Health Condition 1: L709- Acne, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Both male and female patients aged between 18-50 years with erythema after acne
Exclusion criteria
Exclusion criteria: 1.History of drug allergies in previous use 2.Pregnancy and lactation 3.Patients using medications which have drug interactions with Tranexamic Acid. 4.Patients who have been treated orally and topically with retinoid drugs over the past month.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Erythema scoring Grading of efficacy of treatment modality based on Global aesthetic improvement scale Patient satisfaction by Likert ScaleTimepoint: At baseline Every 2 weeks At the end of 8 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects of Topical 1% Hyaluronic Acid gel and Topical 5% Tranexamic acid gel in the treatment of post acne erythemaTimepoint: At baseline Every 2 weeks At the end of 8 weeks | — |
Countries
India
Contacts
Sri Devaraj Urs Medical College